FDG PET/CT evidence of effective treatment of cardiac sarcoidosis with adalimumab

Christina T. Miller, Nadera J. Sweiss, Yang Lu

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

A 53-year-old man with mediastinal lymph node biopsy and cardiac MRI-proven cardiac sarcoidosis (CS) received treatment with pacemaker and steroids. FDG PET/CT showed active CS despite treatment with prednisone and methotrexate. Addition of weekly adalimumab (Humira) injections was introduced for 3 months. Follow-up FDG PET/CT showed complete resolution of CS as well as improvement of other sarcoid lesions in the thoracic lymph nodes.

Original languageEnglish (US)
Pages (from-to)417-418
Number of pages2
JournalClinical nuclear medicine
Volume41
Issue number5
DOIs
StatePublished - Jan 30 2016
Externally publishedYes

Keywords

  • Adalimumab
  • Cardiac MRI
  • Cardiac sarcoidosis
  • FDG PET/CT
  • Humira

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'FDG PET/CT evidence of effective treatment of cardiac sarcoidosis with adalimumab'. Together they form a unique fingerprint.

Cite this